InvestorsHub Logo
icon url

Amatuer17

12/30/20 7:37 AM

#136973 RE: CI Ventures #136964

Interesting agenda - very comprehensive coverage - let’s see if it has any actual progress or just rinse and repeat?
icon url

ombowstring

12/30/20 8:33 AM

#136982 RE: CI Ventures #136964

THIS SOUNDS GOOD, REAL GOOD -

Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities:

1) BLA submissions to Health Canada, MHRA, EMA, and US FDA
2) HIV prevention trial/monotherapy trial
3) Potential revenue from HIV and manufacturing forecast
4) HIV Cure - amfAR
5) EUA submission timelines to same four agencies for COVID-19
6) Long-hauler clinical trial and potential data readout timelines
7) NASH trial and potential interim analysis timeline
8) Cancer trial Breakthrough Therapy designation potential timelines
9) GvHD trial status
10) Stroke/MS new trials in 2021
11) NASDAQ uplisting status


https://www.cytodyn.com/newsroom/press-releases/detail/494/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines